These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28959472)

  • 21. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.
    Adeoye O; Sucharew H; Khoury J; Vagal A; Schmit PA; Ewing I; Levine SR; Demel S; Eckerle B; Katz B; Kleindorfer D; Stettler B; Woo D; Khatri P; Broderick JP; Pancioli AM
    Stroke; 2015 Sep; 46(9):2529-33. PubMed ID: 26243231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
    Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis.
    Al-Salihi MM; Saha R; Ayyad A; Al-Jebur MS; Al-Salihi Y; Roy A; Dalal SS; Rivet D; Spiotta AM; Qureshi AI
    Clin Neurol Neurosurg; 2024 Jan; 236():108097. PubMed ID: 38176219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple hypointense vessels on susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion receiving intravenous thrombolysis.
    Liu YL; Yin HP; Qiu DH; Qu JF; Zhong HH; Lu ZH; Wang F; Liang MQ; Chen YK
    Stroke Vasc Neurol; 2020 Dec; 5(4):361-367. PubMed ID: 32586972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review.
    Marto JP; Kauppila LA; Jorge C; Calado S; Viana-Baptista M; Pinho-E-Melo T; Fonseca AC
    Stroke; 2019 Oct; 50(10):2813-2818. PubMed ID: 31436141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
    Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B
    Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Clot Volume and Permeability on Response to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
    Bilgic AB; Gocmen R; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104541. PubMed ID: 31810719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Unsuspected Infective Endocarditis.
    Gopal M; Lakhani S; Lee VH
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105502. PubMed ID: 33360518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
    Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
    Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of the Telestroke Drip-And-Stay Model: A Systematic Review and Meta-Analysis.
    Waseem H; Salih YA; Burney CP; Abel MA; Riblet N; Kim A; Robbins N
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105638. PubMed ID: 33540336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2017; 2(2):73-83. PubMed ID: 28736623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study.
    Hong JH; Sohn SI; Kang J; Jang MU; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Cho KH; Kim JT; Choi JC; Lee J; Lee JS; Gorelick PB; Bae HJ
    Cerebrovasc Dis; 2016; 42(5-6):387-394. PubMed ID: 27359223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA.
    Shah K; Clark A; Desai SM; Jadhav AP
    Neurocrit Care; 2022 Feb; 36(1):123-129. PubMed ID: 34228264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.